InvestorsHub Logo
Followers 861
Posts 28265
Boards Moderated 1
Alias Born 03/16/2014

Re: None

Wednesday, 11/13/2019 2:08:39 PM

Wednesday, November 13, 2019 2:08:39 PM

Post# of 30463
“Mile High Labs intends to concentrate on the manufacture of CBD isolates.”

That’s the final sentence of this article

Tells you all you need know about where the CBD industry is heading in 2020

Full Spectrum (THC + CBG/CBN/CBC + CBD) and Broad Spectrum (CBG/CBN/CBC + CBD) are OUT

Pure CBD, also known as CBD Isolate (CBD), is IN


Pure CBD Oil products and Processing Hemp into CBD Isolate will be the 2 biggest growth areas in the CBD Oil industry and CANB has put down strong roots in both

CANB is the only publicly traded company in the U.S. that is producing and selling a full line of Pure CBD Oil products

And they are also a grower and processor, partnering with Shi Farms and Mile High Labs, so CANB has the entire supply chain covered, which will bring costs down and maximize gross margins

I’ve been talking about Pure CBD being the FDA’s choice of formulation for awhile now

The clues have laid out courtesy of Dr. Gottlieb, the former FDA Commissioner

More recently, Aurora Cannabis and now Mile High Labs have also publicly gone on record stating that CBD Isolate is the right formulation for 2020

Here is the relevant excerpt in this article:

Mile High Labs unveiled its 400,000 square foot facility for hemp extraction in Broomfield, CO earlier this month. The facility was repurposed from drug manufacture and came replete with a suite of pharmaceutical manufacturing equipment. Mile High Labs intends to concentrate on the manufacture of CBD isolates.


Here is the full article:

https://www.foodnavigator-usa.com/Article/2019/10/17/UNPA-announces-hemp-policy-signs-up-first-CBD-member#


Sleek
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CANB News